Valcyte Side Effects
Generic Name: valganciclovir
Please note - some side effects for Valcyte may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
Side Effects of Valcyte - for the Consumer
Valcyte
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Valcyte:
Seek medical attention right away if any of these SEVERE side effects occur when using Valcyte:Back pain; constipation; diarrhea; dizziness; drowsiness; headache; nausea; stomach pain; trouble sleeping; vomiting.
TopSevere allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chills; confusion; cough; decreased urination; depression; fever; hallucinations; loss of coordination; numbness or tingling of the skin, hands, or feet; seizures; sore throat; swelling of the legs; tremors; unsteady movements; unusual bruising or bleeding; unusual tiredness or weakness; vision changes.
Side Effects by Body System
General
After oral administration, valganciclovir is rapidly converted to ganciclovir. Therefore, side effects that are known to be associated with ganciclovir administration can be expected to occur with the administration of valganciclovir.
Gastrointestinal
Gastrointestinal side effects have included diarrhea (41%), nausea (30%), vomiting (21%), and abdominal pain (15%). Constipation, dyspepsia, abdominal distention, and ascites have also been reported.
Hematologic
Hematologic side effects have included neutropenia (27%), anemia (26%) and thrombocytopenia (6%). Potentially life-threatening bleeding, leukopenia, pancytopenia, and aplastic anemia have been reported. Neutrophil dysplasia with evidence of bone marrow hypoplasia has also been reported.
Immunologic
Immunologic side effects have included graft rejection in transplant patients (24%) and bone marrow depression.
Ocular
Ocular side effects such as retinal detachment (15%) have occurred.
Nervous system
Nervous system side effects such as insomnia (16%), peripheral neuropathy (9%), and paresthesia (8%) have been reported. Neurotoxicity, tremors, dizziness, and convulsions have also been reported.
Renal
Renal side effects have included serum creatinine elevations to greater than 1.5 mg/dL (15%), renal impairment, dysuria, and decreased creatinine clearance.
Oncologic
In animal studies, ganciclovir was found to be carcinogenic. Because valganciclovir could potentially cause cancers, it is considered a potential carcinogen in humans.
Psychiatric
Psychiatric side effects have rarely included psychosis, depression, hallucinations, confusion, and agitation.
Other
Pyrexia (31%), headache (22%), fatigue, pain, edema, peripheral edema, and weakness have been reported with the use of valganciclovir.
Other
Local and systemic infections, sepsis, pharyngitis/nasopharyngitis, upper respiratory tract infection, urinary tract infection, postoperative wound infection, postoperative complications, postoperative pain, increased wound drainage, and wound dehiscence have been reported in transplant patients.
Hypersensitivity
Valganciclovir hypersensitivity has been reported by the manufacturer.
Cardiovascular
Cardiovascular side effects have included hypertension (18%) and hypotension in organ transplant patients.
Hepatic
Hepatic side effects have included abnormal hepatic function.
Metabolic
Metabolic side effects have included hyperkalemia, hypokalemia, hypomagnesemia, hyperglycemia, decreased appetite, dehydration, hypophosphatemia, and hypocalcemia in transplant patients.
Musculoskeletal
Musculoskeletal side effects have included back pain, arthralgia, muscle cramps, and limb pain in transplant patients.
Respiratory
Respiratory side effects have included cough, dyspnea, rhinorrhea, and pleural effusion in transplant patients.
Dermatologic
Dermatologic side effects have included dermatitis, pruritus, and acne in transplant patients.
TopMore resources:
Valcyte - Includes detailed dosage instructions.
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
